High Levels of the PSA (Prostate Specific Antigen) In Patients with Benign Prostatic Hyperplasia and Prostate CancerRishu BansaliMedPub
Lung volume, airway resistance, and compliance have been measured in 19 infants, 18 of whom suffered from the respiratory distress syndrome (RDS) at birth, while the remaining infant was ventilated for persistent apnea and a pneumothorax. Prior to discharge from the neonatal unit, and after recov...
Prostate-specific antigen (PSA) is the tumor marker most widely used in conjunction with digital rectal examination (DRE) for the early detection of prostate cancer (PCa). Due to its limitations, especially the high rate of false positive (FP) results, PSA screening of transplant candidates is...
PSA levels can be detected in the blood, urine, or semen. Blood PSA testing is used as a screening test for prostate cancer. Prostate-specific antigen (PSA) levels by age remain the same across most populations. A PSA level above 4.0 ng/mL in any age group must be investigated. However...
监测与治疗后psa的前列腺癌是一种临床实践的主体,虽然临床实用程序的psa是可变的,取决于疾病的阶段的indi-vidual病人。 翻译结果5复制译文编辑译文朗读译文返回顶部 相关内容 a谢谢你传授给我们知识 Thank you for your transfer to our knowledge;[translate] ...
Stanczyk FZ, Skinner EC, Mertes S, Spahn MF, Lobo RA & Ross RK (1996) Alterations in circulating levels of androgens and PSA during treatment with Finasteride in men at high risk for prostate cancer. In Hormonal Carcinogenesis II, pp. 404- 407 [JJ Li, SA Li, J Gustafsson, S Nandi ...
PSA and PSA velocity (PSAV, rate of PSA change over time) are biomarkers for diagnosis and prognosis of prostate cancer. Men who are at high risk for prostate cancer also have associated comorbidities for which they are taking NSAIDs and statins for long periods; therefore, it is important ...
(2012) Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis. ... C Li,L Xu,X Lin,... - 《Medicine》 被引量: 0发表: 2021年 Statin use and fatal prostate cancer BACKGROUND:Statins are some of the ...
Objective High-dose-rate (HDR) brachytherapy boost represents a method to dose escalate in high-risk prostate cancer; the purpose of this analysis is to report long-term outcomes for a group of high-risk patients with Gleason 8 through 10 prostate cancer treated with HDR brachytherapy boost from...
published in 2018, which enrolled men with nmCRPC and rapidly rising PSA levels. Increases in PSA signal an increased risk that the cancer will spread, or metastasize, outside of the prostate gland. In patients with nmCRPC, rising PSA levels are often the first sign that the cancer is growin...